休克补液辩论:晶体液首选课件_第1页
休克补液辩论:晶体液首选课件_第2页
休克补液辩论:晶体液首选课件_第3页
休克补液辩论:晶体液首选课件_第4页
休克补液辩论:晶体液首选课件_第5页
已阅读5页,还剩29页未读 继续免费阅读

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

1、晶体液 VS 胶体液Crystalloids VS Colloids1,液体种类的选择2,复苏策略(量)3,复苏程度endpoints (度) 液体复苏包括三个主题晶体液胶体液Sesults: Pooled difference in the risk of death with albumin was 6% (95% confidence interval 3% to 9%) with a fixed effects model. These data suggest that for every 17 critically ill patients treated with albumin

2、 there is one additional death.Conclusions: There is no evidence that albumin administration reduces mortality in critically ill patients with hypovolaemia, burns, or hypoalbuminaemia and a strong suggestion that it may increase mortality. Conclusion: Albumin increase the risk of mortality by 6%Desi

3、gn: Systematic review of randomised controlled trials of resuscitation with colloids compared with crystalloids for volume replacement of critically ill patients.Subjects: 37 randomised controlled trialsType of injury: Trauma, Burns, Surgery, Septic and hypovolaemic shock, ARDS, Vascular leak syndro

4、meDesign: Systematic review of randomised controlled trials of resuscitation with colloids compared with crystalloids for volume replacement of critically ill patients; analysis stratified according to patient type and quality of allocation concealment.Subjects: 37 randomised controlled trials were

5、eligible, of which 26 unconfounded trials compared colloids with crystalloids (n = 1622). (The 10 trials that compared colloid in hypertonic crystalloid with isotonic crystalloid (n = 1422) and one trial that compared colloid in isotonic crystalloid with hypertonic crystalloid (n = 38) are described

6、 in the longer version on our website ).SAFE研究: 4% Albumin vs Normal Saline(Saline versus Albumin Fluid Evaluation)双盲随机对照,28天死亡率评估澳大利亚新西兰16个ICU,共6997个病人不同病人群体亚组分析VISEP Study (HES vs Ringers lactate) Efficacy of Volume Substitution and Insulin Therapy in Severe SepsisVISEP Study (HES vs Ringers lacta

7、te) Subjects: Patients were deemed to be eligible if the onset of the syndrome was less than 24 hours before admission to the ICU or less than 12 hours after admission if the condition developed in the ICU. HES group: HES until a limit of 20 mL/kg/day, then preferentially Ringers or other non-colloi

8、d fluidsRL group:Ringers lactateVISEP Study (HES vs Ringers lactate) VISEP Study (HES vs Ringers lactate) P=0.007 between HES dosesP=0.345 between Ringers lactate dosesVISEP Study (HES vs Ringers lactate) 60402000 - 24 h24 - 48 hHemohes ml / kg / BW / 24h22 ml/kg/BW28,274最初 24 hours内38,2100研究期间至少有一天

9、%nn=262VISEP Study (HES vs Ringers lactate) 57.6%30.9%0%25%50%75%22.8%33.0%0%25%50%75%28-day 死亡率90-day 死亡率死亡率 (%)n=162n=100HES 22 ml/kg BW/day *n=162n=99p=0.071P0.001* on at least one study dayVISEP Study (HES vs Ringers lactate) VISEP Study (HES vs Ringers lactate) 33.6%30.9%0%25%50%75%24.2%22.8%0%

10、25%50%75%28-day 死亡率90-day 死亡率死亡率 (%)n=256n=162HESRingers lactaten=256n=162p=0.747p=0.562VISEP 研究 (HES vs. 乳酸林格氏液) - 死亡率 HES 22 ml/kg/BW vs 乳酸林格氏液 -VISEP 研究 (HES vs. 乳酸林格氏液) - 发病率: 乳酸林格氏液 vs. HES 22 ml/kg BW/天 - 晶体液组织水肿晶体液组织水肿In our study, patients who were resuscitated with albumin received less flu

11、id than those who were resuscitated with saline. During the first four days,the ratio of albumin administered to saline administered was approximately 1:1.4. However, there was no significant difference in mean arterial pressure between the groups, and the differences in central venous pressure and heart rate were small. Thus, we believe that the patients in the two groups were resuscitated to similar and acceptable end points.1.32 for the entire stud

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论